Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M337Revenue $M26.4Net Margin (%)-630.8Z-Score-6.1
Enterprise Value $M404EPS $-1.3Operating Margin %-691.1F-Score4
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-642.9Higher ROA y-yY
Price/Book010-y EBITDA Growth Rate %0Quick Ratio4.2Cash flow > EarningsN
Price/Sales8.15-y EBITDA Growth Rate %-15.4Current Ratio4.7Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-65.8Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M173ROI % (ttm)0Gross Margin Increase y-yY

Gurus Latest Trades with AMRN

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AMRNJohn Burbank 2013-03-31 Sold Out -0.08%$6.965 - $9.16
($8.27)
$ 1.93-77%Sold Out0
AMRNJohn Burbank 2012-12-31 Buy 0.08%$7.68 - $12.6
($10.8)
$ 1.93-82%New holding, 250000 sh.250,000
AMRNGeorge Soros 2012-09-30 Sold Out -0.06%$11.17 - $15.49
($13.55)
$ 1.93-86%Sold Out0
AMRNGeorge Soros 2012-06-30 Buy 0.06%$9.47 - $14.74
($11.35)
$ 1.93-83%New holding, 300000 sh.300,000
AMRNGeorge Soros 2011-09-30 Sold Out -0.058%$8.95 - $14.82
($12)
$ 1.93-84%Sold Out0
AMRNGeorge Soros 2011-06-30 Reduce-0.04%$7.39 - $19.5
($15)
$ 1.93-87%Reduce -56.15%285,000
AMRNGeorge Soros 2011-03-31 Reduce-0.04%$7.03 - $9.33
($8.1)
$ 1.93-76%Reduce -42.66%650,000
AMRNGeorge Soros 2010-12-31 Buy 0.12%$2.49 - $8.49
($4.48)
$ 1.93-57%New holding, 1133500 sh.1,133,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AMRN is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


AMRN: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about AMRN :

    Quarterly/Annual Reports about AMRN:

    News about AMRN:

    Articles On GuruFocus.com
    Morning Coffee: Widely Held International Guru Stocks Near 52-Week Lows May 23 2014 
    Weekly Guru Bargains Highlights: PANL, THRX, ZNGA, LORL, AMRN Jan 07 2013 
    Steven Cohen Adds Amarin Corp. Awaiting Drug Approval, Buys Hyatt Hotels Mar 28 2012 
    Soros Funds’ Great Britain Buys and Sells Apr 13 2011 

    More From Other Websites
    AMARIN CORP PLC\UK Financials Aug 15 2014
    Amarin Reports Second Quarter 2014 Financial Results and Provides Update on Operations Aug 07 2014
    AMARIN CORP PLC\UK Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 07 2014
    Amarin Reports Second Quarter 2014 Financial Results and Provides Update on Operations Aug 07 2014
    Amarin to Host Second Quarter 2014 Earnings Conference Call and Webcast Live on Thursday, August 7,... Aug 07 2014
    Amarin to Report Second Quarter 2014 Results and Host Conference Call on August 7, 2014 Aug 05 2014
    Amarin to Report Second Quarter 2014 Results and Host Conference Call on August 7, 2014 Aug 05 2014
    Amarin Moves Higher On Speculation Of Special Protocol Assessment Jul 31 2014
    Amarin Shocker: There's a Reason to be Bullish Right Now Jul 31 2014
    Amarin: Will The Lamb Of Ireland Bleat Or The Lion Of The People Roar? Jul 21 2014
    AMARIN CORP PLC\UK Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jul 10 2014
    Amarin Scrapes The Bottom Of The Barrel Jun 27 2014
    Rick Harrison of Television's "Pawn Stars®" Discusses His Revelations on Seeking Treatment for His... Jun 25 2014
    Update-Moody's downgrades Novasep's probability of default rating to Caa1-PD from B3-PD; outlook... Jun 13 2014
    Stagnant Sales An Ominous Sign For Amarin Jun 12 2014
    Amarin announces Vascepa case study publication Jun 11 2014
    Amarin Announces Publication of Case Study Results Describing Reductions in Multiple Lipid... Jun 11 2014
    Amarin to Present at the Goldman Sachs 2014 Global Healthcare Conference Jun 04 2014
    Amarin to Present at the Jefferies 2014 Global Healthcare Conference May 29 2014
    AMARIN CORP PLC\UK Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a... May 21 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK